| Literature DB >> 26530029 |
Joy J Chebet1, Shannon A McMahon2,3, Jesse A Greenspan4, Idda H Mosha5, Jennifer A Callaghan-Koru6, Japhet Killewo7, Abdullah H Baqui8, Peter J Winch9.
Abstract
BACKGROUND: Family planning has been shown to be an effective intervention for promoting maternal, newborn and child health. Despite family planning's multiple benefits, women's experiences of - or concerns related to - side effects present a formidable barrier to the sustained use of contraceptives, particularly in the postpartum period. This paper presents perspectives of postpartum, rural, Tanzanian women, their partners, public opinion leaders and community and health facility providers related to side effects associated with contraceptive use.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26530029 PMCID: PMC4632271 DOI: 10.1186/s12905-015-0255-5
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.809
Demographic characteristics of postpartum women, their partners, community leaders and health providers
| Postpartum womena ( | Partners of postpartum womenb ( | Community leaders c ( | Community health workers ( | Facility based providers ( | |
|---|---|---|---|---|---|
| Age (years) | |||||
| Mean | 28.56 | 37.14 | 43.00 | 42.66 | 37.17 |
| ( | ( | ( | ( | ( | |
| Median | 28 | 37 | 42 | 43 | 35 |
| Range | 18–43 | 23–60 | 29–65 | 25–52 | 20–57 |
| Gender | |||||
| Female | 35 (100.00) | 0 (0.00) | 0 (0.00) | 9 (47.37) | 9 (75.00) |
| Male | 0 (0.00) | 23 (100.00) | 12 (100.00) | 10 (52.63) | 3 (25.00) |
| District— | |||||
| Morogoro rural | 1 (2.94) | 1 (4.35) | 0 (0.00) | 2 (10.52) | 3 (25.00) |
| Mvomero | 12 (35.29) | 5 (21.74) | 4 (33.33) | 7 (36.84) | 0 (0.00) |
| Kilosa | 10 (29.41) | 11 (47.83) | 3 (25.00) | 3 (15.79) | 9 (75.00) |
| Ulanga | 11 (32.35) | 6 (26.09) | 5 (41.67) | 7 (36.84) | 0 (0.00) |
| Marital status- | |||||
| Married/Cohabiting | 29 (85.29) | 21 (91.30) | 11 (91.67) | 13 (68.42) | -- |
| Single | 5 (14.71) | 1 (4.35) | 0 (0.00) | 3 (15.79) | -- |
| Divorced | 0 (0.00) | 0 (0.00) | 0 (0.00) | 2 (10.53) | -- |
| Not reported | 0 (0.00) | 1 (4.35) | 1 (8.33) | 1 (5.26) | -- |
| Level of education | |||||
| No education | 5 (14.71) | 3 (13.04) | 0 (0.00) | 0 (0.00) | -- |
| Started primary school | 6 (17.65) | 2 (8.70) | 0 (0.00) | 0 (0.00) | -- |
| Completed primary school | 17 (50.00) | 15 (65.22) | 7 (58.33) | 13 (68.42) | -- |
| Started secondary school | 0 (0.00) | 0 (0.00) | 1(8.33) | 1 (5.26) | -- |
| Completed secondary school | 3 (8.82) | 2 (8.70) | 1 (8.33) | 2 (10.53) | -- |
| Other | 0 (0.00) | 0 (0.00) | 1 (8.33) | 1 (5.26) | -- |
| Not reported | 3 (8.82) | 1 (4.35) | 2 (16.67) | 2 (10.53) | -- |
| Self reported literacy | |||||
| Literate | 23 (67.65) | 20 (86.96) | 11 (91.67) | 19 (100.00) | -- |
| Illiterate | 10 (29.41) | 1 (4.35) | 0 (0.00) | 0 (0.00) | -- |
| Not reported | 1 (2.94) | 2 (8.70) | 1 (8.33) | 0 (0.00) | -- |
| Parity | |||||
| Mean | 3.06 | 3.55 | -- | -- | -- |
| ( | |||||
| Median | 2.50 | 3.00 | -- | -- | -- |
| Range | 1–6 | 1–11 | -- | -- | -- |
| Age of infant (months) | |||||
| Mean | 6.14 | 6.45 | -- | -- | -- |
| ( | |||||
| Median | 6.50 | 6.00 | -- | -- | -- |
| Range | 0.03–14.00 | 0.77–13.00 | -- | -- | -- |
| Clinical training | |||||
| Cliniciand | -- | -- | -- | -- | 3 (25.00) |
| Non-cliniciane | -- | -- | -- | -- | 9 (75.00) |
aWomen who have delivered a child within the preceding 14 months
bPartners of postpartum women interviewed
cIncludes politicians, Muslim clerics and Christian ministers
dIncludes Clinical Officers, Assistant Clinical Officers and Assistant Medical Officers with the ability to prescribe drugs
Includes Enrolled Nurses, Registered Nurses, Nurse Midwives and Nursing Officers who do not prescribe drugs
Side effects associated with hormonal contraception by respondent group
| Commodity | Side effect | Respondent group | ||
|---|---|---|---|---|
| Mothers | Fathers | Community | ||
| Injections/ “Depo” | Bloating | X | ||
| Missing menses | X | |||
| Stomach pain | X | X | ||
| Weight gain | X | X | X | |
| Headache | X | |||
| Pills | Sterility | X | X | |
| Nausea | X | |||
| Weight loss | X | X | ||
| Implants/ “sticks” | Cancer | X | ||
| Across hormonal contraceptives | Excessive and/or prolonged bleeding | X | X | X |
| Sterility | X | X | X | |
| Contamination of breastmilk | X | X | X | |
Views on hormonal contraceptives and side effects by respondent group
| Respondent group | Attitudes toward contraceptives and contraceptive side effects | Response to side effects |
|---|---|---|
| Postpartum women | Women are concerned/confused about how hormonal contraceptives function | ● Visit health center to speak with provider |
| Women link side effects to other illnesses/conditions (e.g., impaired child development, sterility) | ● Abstain from, switch or discontinue hormonal contraceptive use | |
| Partners of postpartum women | Husbands/partners primarily concerned about wife/partner experiencing side effects (e.g., losing excessive blood, feeling ill and/or becoming infertile) or passing illness to breastfeeding children. | ● Encourage woman to discontinue or change contraceptive method |
| ● Use condoms to avoid side effects | ||
| ● Abstain while partner is breastfeeding | ||
| Community members including CHWs, religious and political leaders | Religious authorities pressure families to avoid FP as it “kills God’s eggs” and could extend the duration of menses thereby inhibiting religious participation | ● Encourage families to avoid all FP methods—especially hormonal contraceptives |
| Community impressions that FP side effects foster laziness and may induce infertility | ● Encourage women to discontinue use to avoid fatigue/laziness and infertility | |
| Health care providers | Providers describe challenges to counseling on FP and side effects especially time constraints. Providers have an impression that women are disinterested in counseling and “only want to get the method and go” | ● Encourage women to continue with method if side effects are not severe |
| Providers perceive the distribution of contraception to be more important than discussion of side effects | ● Encourage alternative methods in instance of severe side effects (and provide these methods) | |
| Providers weigh the benefit of secrecy (associated with injectables) over the drawback of side effects among patients whose husbands oppose contraceptive use | ● Allow women to choose their preferred contraceptive method, notwithstanding potential side effects |